Onconome, Inc. - Product Pipeline Analysis
Reference Code: GDME439PD Publication Date: NOV 2010
Company Snapshot Company Overview
Key Information
Onconome, Inc. (Onconome), is a privately-held biomedical company that
Onconome, Inc., Key Facts is engaged in the discovery, development and marketing of biomarkers
used in the early detection of prostrate, colon, lungs, breast, liver,
Web Address www.onconome.com
pancreatic and stomach cancers. The company’s product pipeline is
Turnover (in USD Million) 0.80 based on the use of nuclear matrix proteins (NMPs) as organ-specific
biomarkers indicative of malignant transformation. It also focuses on the
Number of Employees 10 in-licensing program of novel proteomic and genomic biomarkers and
Industry Pharmaceuticals and Healthcare biomarker combinations with diagnostic, prognostic, for the treatment of
Source:Primary / Secondary Research cancer and other major diseases with unmet diagnostic needs.
GlobalData
Onconome, Inc. Pipeline Products
Onconome, Inc. Key Pipeline Products by Equipment Onconome, Inc. Key Pipeline Products by Therapy Area
Type
Equipment Type No of Products Therapy Area No of Products
Immuno Chemistry 10 Breast cancer 2
Source: Primary / Secondary Research Pancreatic cancer 2
GlobalData
Prostate cancer 2
Cardiac diseases 1
Colorectal cancer 1
Diabetic nephropathy 1
Lung cancer 1
Source: Primary / Secondary Research
GlobalData
Onconome, Inc. Key Pipeline Products by Development Stage
Developmental Stage No of Products
Clinicals 3
Pre-Clinicals 1
Early development 6
Source: Primary / Secondary Research
GlobalData
Onconome, Inc. Key Pipeline Products by Trial Phase
Trial Phase No of Products
Phase IV -
Phase III -
Phase II -
Phase I -
Source: Primary / Secondary Research
GlobalData
Note : (-) indicates 'Not Available'
Onconome, Inc. - Product Pipeline Analysis Reference Code: GDME439PD
Source : www.globalcompanyintelligence.com Page 1
Table of Contents
Table of Contents................................................................................................................................................................................................................................................................... 2
List of Tables .......................................................................................................................................................................................................................................................................... 3
List of Figures......................................................................................................................................................................................................................................................................... 3
Key Facts ............................................................................................................................................................................................................................................................................... 4
Onconome, Inc. - Major Products and Services..................................................................................................................................................................................................................... 5
Onconome, Inc. Pipeline Products by Equipment Type .................................................................................................................................................................................................. 6
Onconome, Inc. Pipeline Products by Development Stage ............................................................................................................................................................................................. 8
Onconome, Inc. Pipeline Products by Therapy Area..................................................................................................................................................................................................... 10
Breast cancer diagnostic assay ..................................................................................................................................................................................................................................... 13
Product Status......................................................................................................................................................................................................................................................... 13
Product Description ................................................................................................................................................................................................................................................. 13
Breast Cancer prognostic assay.................................................................................................................................................................................................................................... 13
Product Status......................................................................................................................................................................................................................................................... 13
Product Description ................................................................................................................................................................................................................................................. 13
Cardiovascular Prognostic assay .................................................................................................................................................................................................................................. 13